VPC
Vestal Point Capital Portfolio holdings
AUM
$2.73B
1-Year Est. Return
128.57%
This Fund
S&P 500
1 Year Est. Return
+128.57%
AUM
$2.73B
AUM Growth
+$522M
(+24%)
Holding
105
Top Buys
| 1 | +$134M | |
| 2 | +$118M | |
| 3 | +$104M | |
| 4 |
ABVX
Abivax
ABVX
|
+$98.2M |
| 5 |
Merck
MRK
|
+$72.7M |
Top Sells
| 1 | +$104M | |
| 2 | +$87.8M | |
| 3 | +$76.8M | |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$70.3M |
| 5 |
Becton Dickinson
BDX
|
+$60.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Arcus Biosciences
RCUS
$3.12B
| – | – |
-250,000
|
|
||
102
Regeneron Pharmaceuticals
REGN
$77.4B
| – | – |
-25,000
|
|
||
|
VTYX
103
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-2,050,000
|
|
||
104
Traws Pharma
TRAW
$12.3M
| – | – |
-150,000
|
|
||
|
TVRD
105
Tvardi Therapeutics
TVRD
$30M
| – | – |
-167,000
|
|